Search Results
Nov 03, 2025, 16:01 ET HALOZYME RAISES 2025 FINANCIAL GUIDANCE AND REPORTS STRONG THIRD QUARTER 2025 FINANCIAL AND OPERATING RESULTS
SAN DIEGO, Nov. 3, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") today reported its financial and operating results for the third quarter ended September 30, 2025 and provided an update
More news about: Halozyme Therapeutics, Inc.
Oct 30, 2025, 13:30 ET vivo X300 Series Debuts in Europe with 200 MP ZEISS Ultra-Clear Imaging to Advance Flagship Excellence
The series presents a diverse color palette designed to complement a variety of styles. The X300 model features Phantom Black and Halo Pink. The X300 Pro retains Phantom Black, and Dune Brown, delivering a classic and mature look. vivo VISION+
More news about: vivo
Oct 30, 2025, 13:30 ET vivo X300 Series Makes Global Debut with 200 MP ZEISS Ultra-Clear Imaging to Advance Flagship Excellence
The series presents a diverse color palette designed to complement a variety of styles. The X300 model features Phantom Black and Mist Blue, alongside Halo Pink—a vibrant and fashionable shade that embodies a chic and refined aesthetic—together with Iris Purple and Summit Red. The X300 Pro retains Phantom
More news about: vivo
Oct 30, 2025, 13:15 ET InventHelp Inventors Develop Improved Motorcycle Helmet (LOS-373)
helmet that would allow a motorcycle rider to signal when braking and turning," said one of two inventors, from Los Angeles, Calif., "so we invented the HALO HELMET. Our helmet design would attract instant attention, and it would provide added protection and peace of mind for safety-conscious motorcyclists."
More news about: InventHelp
Oct 28, 2025, 08:03 ET Mercy BioAnalytics Publishes Validation Study in Gynecologic Oncology Demonstrating Unprecedented Performance of Blood Test for Early Detection of Ovarian Cancer
co-localization to interrogate highly abundant, blood-based extracellular vesicles that carry unique cancer signatures from their parent cells. The Mercy Halo platform is designed to detect early-stage cancer, when it is most treatable, and enhance the quality of life for cancer patients and their families.
More news about: Mercy BioAnalytics
Oct 28, 2025, 00:01 ET TCL Electronics (01070.HK) Delivers Simultaneous Growth in TV Sales and Revenue for the First Three Quarters of 2025
such as cross-colour and colour halo that have plagued the industry for many years, but also reshaped the picture quality evaluation system with its All-domain Halo Control Technology. This solution, which features 100% BT.2020 global high color gamut and All-domain Halo Control Technology, is regarded
More news about: TCL Electronics Holdings Limited
Oct 24, 2025, 14:30 ET AT&T Launches Connectopia at Intuit Dome, Elevating the Game Day Experience
experience" said Gillian Zucker, CEO of Halo Sports & Entertainment. "We set out to build an arena that could elevate the game and bring fans closer – not just to the team, but to each other. AT&T has helped make that vision real. From the power behind the Halo Board to immersive activations like
More news about: AT&T
Oct 22, 2025, 10:20 ET Tint World® Automotive Styling Centers™ Partners with Oracle Lighting to Deliver Premium Automotive Lighting Solutions
quality, safety, and customization Oracle is known for." Oracle Lighting's catalog includes headlights, taillights, fog lights, halo kits, off-road lighting, LED accent lights, and custom lighting accessories, all designed to elevate style, safety, and performance. With a streamlined
More news about: Tint World
Oct 21, 2025, 16:30 ET Citius Pharmaceuticals Announces the Closing of Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase
More news about: Citius Pharmaceuticals, Inc.
Oct 21, 2025, 08:30 ET Halozyme to Report Third Quarter 2025 Financial and Operating Results
SAN DIEGO, Oct. 21, 2025 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its third quarter 2025 financial and operating results on Monday, November 3, 2025, following the close
More news about: Halozyme Therapeutics, Inc.
Oct 21, 2025, 08:00 ET Citius Pharmaceuticals Announces a Registered Direct Offering of $6.0 Million Priced At-The-Market Under Nasdaq Rules
salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase
More news about: Citius Pharmaceuticals, Inc.
Oct 21, 2025, 07:00 ET Muon Space to Integrate SpaceX's Starlink Mini Space Lasers Into Its Halo™ Satellite Platform
will be launching its first Starlink-enabled Halo satellite in Q1 2027. Full‑Stack Advantage Muon's vertically integrated Halo technology stack – including the MuSat XL
More news about: Muon Space
Oct 20, 2025, 09:00 ET Aperia Launches Nearby Issues Feature to Boost Technician Efficiency
offers the most comprehensive, user-friendly line-up of tire management solutions available to commercial fleets worldwide, including Halo® Tire Inflator, Halo Connect®, and Halo Connect i3™. For more information, visit AperiaTech.com. Media Contact:Aperia TechnologiesAperia
More news about: Aperia Technologies
Oct 20, 2025, 08:37 ET Citius Oncology Signs U.S. Distribution Agreement with McKesson to Support LYMPHIR™ Commercial Launch
salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase
More news about: Citius Oncology, Inc.
Oct 20, 2025, 07:00 ET Driving the Future of School Bus Safety: First Student's HALO™ Technology Platform - Powered with Advanced AI Insights - Takes Center Stage at the NYSE
integrates every aspect of operations, now enhanced with an advanced AI-powered technology solution through its strategic partnership with Samsara. Together, HALO and Samsara are delivering rides that are smarter, safer, and more connected for the 5.5 million student journeys First Student supports every day.
More news about: First Student
Oct 17, 2025, 17:00 ET Citius Pharmaceuticals and Citius Oncology to Participate in Upcoming October 2025 Conferences
salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase
More news about: Citius Pharmaceuticals, Inc.
Oct 16, 2025, 09:00 ET Temple Raises $5M To Build Privacy Focused Technical Stack To Trade Capital Markets On Canton
The round was led by Paper Ventures and included participation from YZi, CMT Digital, Sfermion, Halo Capital, Protagonist, 5N Canton, Eterna Capital, AMA, GSR, Selini, Presto and G20.
More news about: Temple Digital Group
Oct 16, 2025, 09:00 ET Temple Raises $5M To Build Privacy Focused Technical Stack To Trade Capital Markets On Canton
The round was led by Paper Ventures and included participation from YZi, CMT Digital, Sfermion, Halo Capital, Protagonist, 5N Canton, Eterna Capital, AMA, GSR, Selini, Presto and G20.
More news about: Temple Digital Group
Oct 16, 2025, 08:47 ET Citius Oncology Signs Exclusive Commercialization Agreement with EVERSANA to Support Planned Q4 2025 Launch of LYMPHIR™
salvage catheters in patients with catheter-related bloodstream infections, and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. A Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase
More news about: Citius Oncology, Inc.
Oct 14, 2025, 22:37 ET MegazoneCloud's AIR Studio Earns Korea's First ISO/IEC 42001 Certification for AI Management Systems
through its suite of proprietary cloud, AI, and security platforms—including AIR Studio, Space CloudOps, Hyper Billing, and HALO Security. Guided by its vision "Transform Tomorrow, Together," MegazoneCloud is dedicated to helping customers build
More news about: MegazoneCloud
Oct 14, 2025, 17:39 ET KROWN PRODUCE DRIVES DEEPER INTO THE RACING SPACE WITH ASTON MARTIN ARAMCO FORMULA ONE™ TEAM PARTNERSHIP
driver and fellow Canadian, Lance Stroll. To mark the next phase of this elevated partnership, the Krown logo will take a prime position beneath the halo of both cars during the 2025 Formula 1 MSC Cruises United States Grand Prix, a visible symbol of the company's growing commitment to the sport, its
More news about: Aston Martin Aramco Formula One™ Team; Krown Produce
Oct 14, 2025, 16:09 ET Lancôme and Monique Lhuillier Celebrate Breathtaking Partnership at Fall 2026 Bridal Runway Show
dimensional warmth. For added luminosity, Lancôme Teint Idôle Ultra Wear C.E. Skin Transforming Highlighter in 01 Light Glow or 04 Halo Glow was applied to the high points of the face. Brows were softly defined using the Lancôme Brow Define Pencil, enhancing each model's natural
More news about: Lancôme
Oct 14, 2025, 07:00 ET First Student's Groundbreaking HALO Platform Named Fast Company's "Next Big Thing In Tech" for Creating Safer, Smarter, and More Connected School Transportation
HALO represents a significant step forward for the industry, bringing together advanced AI, real-time data, and predictive analytics into one unified, intelligent
More news about: First Student
Oct 09, 2025, 10:00 ET First Student's HALO™ Named a TIME Best Invention of 2025
HALO was developed to address fragmented systems – a long-standing problem in school transportation. Prior to a unified platform, First Student worked with multiple vendors and manual processes to manage its transportation systems. HALO unifies every aspect of K-12 transportation
More news about: First Student
Oct 08, 2025, 10:00 ET Dizzion Launches Halo: A Secure Every Browser Built for the Modern Workforce
workspace solutions, today announced the launch of Dizzion Halo, a Secure Every Browser (SEB) platform designed to transform everyday browsers into enterprise-grade security endpoints. Built for flexibility, visibility, and zero-trust enforcement, Halo empowers organizations to secure their browser environments
More news about: Dizzion, Inc.